Literature DB >> 16341492

Surgical treatment of a superior sulcus tumor in a patient with idiopathic thrombocytopenic purpura: report of a case.

Takahiro Nakajima1, Akira Iyoda, Toshihiko Iizasa, Yukio Saitoh, Kenzo Hiroshima, Takehiko Fujisawa.   

Abstract

We herein report a resection of a superior sulcus tumor in a patient with idiopathic thrombocytopenic purpura. A resection of the left upper lobe of the lung, left subclavian artery, and left first to third ribs, as well as a reconstruction of the left subclavian artery, were performed. Postoperative hemorrhaging was controlled due to preoperative high-dose intravenous immunoglobulin therapy and a platelet transfusion both during and following surgery. The resected tumor was diagnosed to be a pulmonary pleomorphic carcinoma, which was pathologically determined to be T3N0M0-Stage 2B. The patient remained in good condition for 20 months following the surgery; however, he eventually died due to bone metastases.

Entities:  

Mesh:

Year:  2005        PMID: 16341492     DOI: 10.1007/s00595-005-3069-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  7 in total

1.  Double lung cancer combined with idiopathic thrombocytopenic purpura. A case report.

Authors:  Y Nonami; T Yamashiro; A Yamamoto; M Kume; N Hisa; S Yoshida; H Taguchi
Journal:  J Cardiovasc Surg (Torino)       Date:  1999-12       Impact factor: 1.888

2.  Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).

Authors:  V W Rusch; D J Giroux; M J Kraut; J Crowley; M Hazuka; D Johnson; M Goldberg; F Detterbeck; F Shepherd; R Burkes; T Winton; C Deschamps; R Livingston; D Gandara
Journal:  J Thorac Cardiovasc Surg       Date:  2001-03       Impact factor: 5.209

3.  High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura.

Authors:  R E Schmidt; U Budde; G Schäfer; I Stroehmann
Journal:  Lancet       Date:  1981-08-29       Impact factor: 79.321

4.  A new surgical approach to apical segment lung diseases, including carcinomas and inflammatory diseases.

Authors:  T Tatsumura; H Sato; A Mori; M Miyazaki; S Koyama; M Tsujimoto; T Furuno
Journal:  J Thorac Cardiovasc Surg       Date:  1994-01       Impact factor: 5.209

Review 5.  Chronic idiopathic thrombocytopenic purpura.

Authors:  J N George; M A el-Harake; G E Raskob
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

Review 6.  [Aortic valve replacement in a patient with chronic idiopathic thrombocytopenic purpura].

Authors:  S Tanaka; S Ishihara; S Hara; H Niinami
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1994-02

Review 7.  Changes in the treatment of Pancoast tumors.

Authors:  Frank C Detterbeck
Journal:  Ann Thorac Surg       Date:  2003-06       Impact factor: 4.330

  7 in total
  2 in total

1.  Surgical treatment of cecal cancer in a patient with Glanzmann's thrombasthenia: report of a case.

Authors:  Akira Kabashima; Naoyuki Ueda; Yusuke Yonemura; Kojiro Mashino; Kyuzo Fujii; Tetsuo Ikeda; Hideya Tashiro; Hisanobu Sakata
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

2.  Perioperative care of a patient with refractory idiopathic thrombocytopenic purpura undergoing total knee arthroplasty.

Authors:  Rohit Singhal; Veera Gudimetla; Andrew Stewart; Karen L Luscombe; Charalambos P Charalambous
Journal:  Knee Surg Relat Res       Date:  2012-11-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.